ReviewTropical animal health and production2026
Strategies to reduce cholesterol content in poultry eggs: an overview.
Review in Tropical animal health and production, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Poultry eggs are an affordable and nutrient-dense source of high-quality protein and essential micronutrients; however, the relatively high cholesterol content of egg yolk has raised persistent health concerns, particularly for populations vulnerable to cardiovascular and metabolic disorders. Although numerous strategies have been explored to reduce egg cholesterol, existing studies remain fragmented and often focus on isolated nutritional interventions without integrating physiological regulation, genetic background, and molecular mechanisms governing cholesterol synthesis, transport, and yolk deposition. This review provides a mechanism-based synthesis of conventional and emerging approaches for low-cholesterol designer egg production by integrating nutritional, endocrine, genetic, and omics perspectives. Peer-reviewed studies on dietary feed supplementation with vitamins, minerals, amino acids, plant bioactives, fish oil, probiotics, microalgae, and nanotechnology-based feed formulations, along with genomics and multi-omics research, were critically evaluated. Evidence indicated that most interventions reduce egg yolk cholesterol indirectly by modulating hepatic lipoprotein synthesis, intestinal sterol absorption, and lipid transport rather than directly suppressing cholesterol biosynthesis. Probiotics, microalgae, and bioactive phytochemicals demonstrate promising hypocholesterolemic effects, while omics-driven approaches offer long-term potential for genetic improvement and trait stability. Overall, egg yolk cholesterol deposition is regulated by a complex, multifactorial network involving hormonal control, lipid metabolism, and genetic determinants, underscoring the limitations of single-factor approaches. Integrated nutritional and genetic strategies therefore represent the most sustainable pathway for producing low-cholesterol “designer eggs” without compromising hen performance or egg quality, supporting public health nutrition and aligning with Sustainable Development Goals, SDG-2, SDG-3, and SDG-12.
Indexed as
Identifiers
41770424What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.